Company profile
Remix Therapeutics
Reprogramming RNA Processing, Designing Therapeutic Solutions
- Industry
- Biotechnology Research
- Employees
- 50
- Headquarters
- Watertown, MA, MA
- Founded
- 2018
- LinkedIn followers
- 9,814
- Office locations
- 1
Remix Therapeutics company summary
Remix Therapeutics is a company in the Biotechnology Research industry, headquartered in Watertown, MA, MA, founded in 2018. On LinkedIn the company has around 50 employees and 9,814 followers.
What technology does Remix Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Remix Therapeutics
Remix is working to transform patient's lives through modulation of RNA processing and addressing drug targets in diseases of high unmet medical need. We are a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin. Remix's REMaster™ technology platform leverages cutting-edge data science, biomolecular sciences and chemistry approaches to identify orally administered compounds that modulate gene expression. Remix's innovative therapeutic approach led to the discovery of REM-422, a first-in-class RNA processing modulator in oncology, now being evaluated in Phase 1 clinical studies to treat acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (HR-MDS) and adenoid cystic carcinoma (ACC).
Where is Remix Therapeutics located?
Remix Therapeutics lists 1 location.
Compare companies similar to Remix Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Remix Therapeutics remixtx.com | Biotechnology Research | 50 | 2018 | Watertown, MA, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Remix Therapeutics
What does Remix Therapeutics do?
Remix is working to transform patient's lives through modulation of RNA processing and addressing drug targets in diseases of high unmet medical need. We are a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin. Remix's REMaster™ technology platform leverages cutting-edge data science, biomolecular sciences and chemistry approaches to identify orally administered compounds that modulate gene expression. Remix's innovative therapeutic approach led to the discovery of REM-422, a first-in-class RNA processing modulator in oncology, now being evaluated in Phase 1 clinical studies to treat acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (HR-MDS) and adenoid cystic carcinoma (ACC).
How many employees does Remix Therapeutics have?
Remix Therapeutics has around 50 employees on LinkedIn.
Where is Remix Therapeutics headquartered?
Remix Therapeutics is headquartered in Watertown, MA, MA.
When was Remix Therapeutics founded?
Remix Therapeutics was founded in 2018.
Build a lead list from companies like Remix Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.